🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: atezolizumab + avastin + platinum-based chemotherapy

Found 18 matching trials

A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)

PHASE2

This is a phase 2/3, global, multicenter, open-label, multi-cohort study de...

Status

Active Not Recruiting

Location

UC Davis

Start Date

2017-09-22

Trial ID

NCT03178552

Treatments Being Tested

Alectinib Atezolizumab Pemetrexed Cisplatin Carboplatin Gemcitabine Entrectinib Cobimetinib Vemurafenib Bevacizumab Divarasib Docetaxel

A Study to Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours

PHASE1

This study has 2 parts. The first part was open to adults with advanced non...

Status

Completed

Location

University of Alabama at Birmingham

Start Date

2018-07-05

Trial ID

NCT03468426

Treatments Being Tested

BI 836880 Ezabenlimab

A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer

PHASE2

This phase II trial compares the effect of adding bevacizumab and atezolizu...

Status

Active Not Recruiting

Location

Sutter Auburn Faith Hospital

Start Date

2022-12-07

Trial ID

NCT05211323

Treatments Being Tested

Atezolizumab Bevacizumab Biospecimen Collection Cisplatin Computed Tomography Conventional Magnetic Resonance Imaging Gemcitabine Hydrochloride

Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic Tumors

PHASE1

This first-in-human open-label, multicenter, dose-escalation and expansion ...

Status

Completed

Location

Honor Health Research Institute

Start Date

2016-05-23

Trial ID

NCT02794571

Treatments Being Tested

Atezolizumab Tiragolumab Carboplatin Cisplatin Pemetrexed Paclitaxel Etoposide Capecitabine Bevacizumab Pembrolizumab

A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site

PHASE2

This study will compare the efficacy and safety of molecularly-guided thera...

Status

Completed

Location

Blacktown Hospital

Start Date

2018-07-10

Trial ID

NCT03498521

Treatments Being Tested

Alectinib Vismodegib Ipatasertib Olaparib Erlotinib Bevacizumab Vemurafenib Cobimetinib Trastuzumab Subcutaneous (SC)Pertuzumab Atezolizumab Carboplatin Paclitaxel Cisplatin Gemcitabine Entrectinib Ivosidenib Pemigatinib

First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.

PHASE3

First-line immunotherapy-based standard of care and local ablative treatmen...

Status

Recruiting

Location

Institut de Radiothérapie du Sud de l'Oise

Start Date

2025-09-09

Trial ID

NCT06840782

Treatments Being Tested

Radical local treatment SoC-based immunotherapy (+/- chemotherapy)

ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab

PHASE3

This is a phase III, randomized, double-blinded, comparative, multi-centre ...

Status

Completed

Location

Krankenhaus der Barmherzigen Brüder Graz

Start Date

2016-09-22

Trial ID

NCT02891824

Treatments Being Tested

atezolizumab + avastin + platinum-based chemotherapy placebo + avastin + platinum-based chemotherapy

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

PHASE2

This phase II/III compares the standard therapy (chemotherapy plus cetuxima...

Status

Active Not Recruiting

Location

University of Arkansas for Medical Sciences

Start Date

2023-03-13

Trial ID

NCT05063552

Treatments Being Tested

Atezolizumab Bevacizumab Biospecimen Collection Carboplatin Cetuximab Cisplatin Computed Tomography Docetaxel Echocardiography Test Magnetic Resonance Imaging Positron Emission Tomography

Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC

PHASE3

This randomized, Phase III, multicenter, open-label study designed to evalu...

Status

Unknown

Location

Samsung Medical Center

Start Date

2019-08-27

Trial ID

NCT03991403

Treatments Being Tested

Atezolizumab(Tecentriq)Pemetrexed Bevacizumab Carboplatin Paclitaxel Carboplatin or cisplatin

Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor

PHASE2

This is a Phase II, two part trial (A and B), open label study of Atezolizu...

Status

Completed

Location

Florida Cancer Specialists - South

Start Date

2019-08-30

Trial ID

NCT03977467

Treatments Being Tested

Atezolizumab Standard of Care Chemotherapy Tiragolumab

Previous Next